To be validated as a CDF Patient Advocate you must first complete the registration process. Click here to register.

* 1. Please enter your contact information.

* 2. How many clinical phases are there in therapeutics development?

* 3. What does each clinical phase test?

* 4. What types of studies are considered the “gold standard?”  Why?

* 5. What is Epidemiology?

* 6. An Efficacy Trial compares what?

* 7. Dr. Adelman argues that the bar is getting higher for the development of therapeutics. Why does he believe that?

* 8. List as many reasons as you can for why the drug process is slow. Which of these reasons protect the interests of patients? 

* 9. If patients are fully engaged in a research project might they offer input that could make the research process less expensive and/or more efficient? Is this possible without jeopardizing patient safety?